Literature DB >> 30088164

The predictive power of transcranial sonography in movement disorders: a longitudinal cohort study.

Daniela Monaco1, Daniela Berg2, Astrid Thomas3, Vincenzo Di Stefano3, Filomena Barbone3, Michela Vitale3, Camilla Ferrante3, Laura Bonanni3, Marta Di Nicola4, Tonia Garzarella5, Luciano Paolo Marchionno6, Giovanni Malferrari7, Rocco Di Mascio8, Marco Onofrj3, Raffaella Franciotti9.   

Abstract

Transcranial sonography (TCS) is a noninvasive, easily performed, and commonly available neuroimaging technique useful for the study of brain parenchyma in movement disorders. This tool has been increasingly used in the diagnosis of Parkinson's disease and atypical parkinsonism. The aim of the study was to evaluate the applicability of this technique as supportive tool in the early diagnosis of movement disorders. We performed TCS on 315 individuals which were diagnosed as healthy controls or affected by idiopathic Parkinson's disease, monogenetic subtypes of Parkinson's disease, atypical parkinsonism, and Dementia with Lewy bodies. Five TCS diagnostic patterns were defined on the basis of substantia nigra's and lenticular nuclei's echogenicity. TCS evaluations were performed by two blinded neuro-sonographers. Clinical diagnosis on all individuals was performed at baseline and at 4-year follow-up. The concordance rate between TCS patterns and clinical diagnosis and the specificity of TCS pattern to discriminate each group of individuals were compared at baseline and at follow-up. The concordance rate between TCS patterns and clinical diagnosis of all individuals was 84% at baseline and increased at follow-up (91%) significantly (p = 0.01). The specificity of TCS pattern in the comparison between patients diagnosed as affected by idiopathic Parkinson's disease and atypical parkinsonism showed a significant increase at follow-up (p = 0.03). Our study strongly confirms the role of TCS as a noninvasive and cost-effective tool in early diagnosis of movement disorders.

Entities:  

Keywords:  Atypical parkinsonism; Dementia with Lewy bodies; Idiopathic Parkinson’s disease; Lenticular nuclei; Substantia nigra; Transcranial sonography

Mesh:

Year:  2018        PMID: 30088164     DOI: 10.1007/s10072-018-3514-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  35 in total

Review 1.  Transcranial sonography in movement disorders.

Authors:  Petra Bartova; David Skoloudik; Michal Bar; Pavel Ressner; Petr Hlustik; Roman Herzig; Petr Kanovsky
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2008-12       Impact factor: 1.245

Review 2.  EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease.

Authors:  A Berardelli; G K Wenning; A Antonini; D Berg; B R Bloem; V Bonifati; D Brooks; D J Burn; C Colosimo; A Fanciulli; J Ferreira; T Gasser; F Grandas; P Kanovsky; V Kostic; J Kulisevsky; W Oertel; W Poewe; J-P Reese; M Relja; E Ruzicka; A Schrag; K Seppi; P Taba; M Vidailhet
Journal:  Eur J Neurol       Date:  2013-01       Impact factor: 6.089

3.  Microglia activation is related to substantia nigra echogenicity.

Authors:  D Berg; J Godau; P Riederer; M Gerlach; T Arzberger
Journal:  J Neural Transm (Vienna)       Date:  2010-11-06       Impact factor: 3.575

4.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

5.  Sonographic discrimination of dementia with Lewy bodies and Parkinson's disease with dementia.

Authors:  Uwe Walter; Dirk Dressler; Alexander Wolters; Matthias Wittstock; Brigitte Greim; Reiner Benecke
Journal:  J Neurol       Date:  2005-11-04       Impact factor: 4.849

6.  Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's disease.

Authors:  Daniela Berg; Stefanie Behnke; Klaus Seppi; Jana Godau; Stefanie Lerche; Philipp Mahlknecht; Inga Liepelt-Scarfone; Christoph Pausch; Niko Schneider; Alexandra Gaenslen; Kathrin Brockmann; Karin Srulijes; Heiko Huber; Isabel Wurster; Heike Stockner; Stefan Kiechl; Johann Willeit; Arno Gasperi; Klaus Fassbender; Thomas Gasser; Werner Poewe
Journal:  Mov Disord       Date:  2012-10-31       Impact factor: 10.338

Review 7.  Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis.

Authors:  Giovanni Rizzo; Massimiliano Copetti; Simona Arcuti; Davide Martino; Andrea Fontana; Giancarlo Logroscino
Journal:  Neurology       Date:  2016-01-13       Impact factor: 9.910

8.  Second consensus statement on the diagnosis of multiple system atrophy.

Authors:  S Gilman; G K Wenning; P A Low; D J Brooks; C J Mathias; J Q Trojanowski; N W Wood; C Colosimo; A Dürr; C J Fowler; H Kaufmann; T Klockgether; A Lees; W Poewe; N Quinn; T Revesz; D Robertson; P Sandroni; K Seppi; M Vidailhet
Journal:  Neurology       Date:  2008-08-26       Impact factor: 9.910

9.  The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study.

Authors:  Alexandra Gaenslen; Barbara Unmuth; Jana Godau; Inga Liepelt; Adriana Di Santo; Katherine Johanna Schweitzer; Thomas Gasser; Hans-Jürgen Machulla; Matthias Reimold; Kenneth Marek; Daniela Berg
Journal:  Lancet Neurol       Date:  2008-04-03       Impact factor: 44.182

Review 10.  Diagnostic Accuracy of Transcranial Sonography of the Substantia Nigra in Parkinson's disease: A Systematic Review and Meta-analysis.

Authors:  Dun-Hui Li; Ya-Chao He; Jun Liu; Sheng-Di Chen
Journal:  Sci Rep       Date:  2016-02-16       Impact factor: 4.379

View more
  3 in total

1.  Reply to Comment on: A 57-Year-Old Woman With Progressive Left Hand Clumsiness and Falls.

Authors:  Vijayashankar Paramanandam; Diana Angelika Olszewska; Bhattacharjee Shakya; Albi Jose Chalissery; Martin O'Connell; Michael Farrell; Tim Lynch
Journal:  Mov Disord Clin Pract       Date:  2020-05-16

2.  Lentiform Nucleus Hyperechogenicity in Parkinsonian Syndromes: A Systematic Review and Meta-Analysis with Consideration of Molecular Pathology.

Authors:  Daniel Richter; Aristeidis H Katsanos; Christoph Schroeder; Georgios Tsivgoulis; George P Paraskevas; Thomas Müller; Andrei V Alexandrov; Ralf Gold; Lars Tönges; Christos Krogias
Journal:  Cells       Date:  2019-12-18       Impact factor: 6.600

3.  Increased substantia nigra echogenicity correlated with visual hallucinations in Parkinson's disease: a Chinese population-based study.

Authors:  Ting Li; Jing Shi; Bin Qin; Dongsheng Fan; Na Liu; Jingnian Ni; Tianqing Zhang; Hufang Zhou; Xiaoqing Xu; Mingqing Wei; Xuekai Zhang; Xiangzhu Wang; Jianping Liu; Yongyan Wang; Jinzhou Tian
Journal:  Neurol Sci       Date:  2019-11-22       Impact factor: 3.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.